[EN] INHIBITORS OF PURINE IMPORT IN PARASITES AND USES THEREOF<br/>[FR] INHIBITEURS DE L'IMPORTATION DE PURINE DANS DES PARASITES ET UTILISATIONS DE CES INHIBITEURS
申请人:UNIV COLUMBIA
公开号:WO2019040869A1
公开(公告)日:2019-02-28
This invention relates to compounds for treating a protozoan parasitic infection and to pharmaceutical compositions comprising the compounds; and to methods of using the compounds and compositions to treat parasitic infections.
[EN] HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS<br/>[FR] DERIVES HETEROCYCLIQUES UTILISES COMME AGONISTES DES RECEPTEURS GPCR
申请人:PROSIDION LTD
公开号:WO2005061489A1
公开(公告)日:2005-07-07
Compounds of Formula (I), R1-A-V-B-R2; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.
In the presence of a supported gold–palladium alloy nanoparticle catalyst (Au–Pd/Al2O3), various kinds of N-substituted anilines can be synthesized from non-aromatic compounds.
N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
申请人:Morie Toshiya
公开号:US20090082463A1
公开(公告)日:2009-03-26
The invention provides the following compound (I):
wherein R
1
is methoxy group, hydroxyl group or hydrogen atom; R
2
is hydrogen atom, C
1-4
alkyl group, C
1-4
alkylcarbonyl group or arylcarbonyl group; D is a group of the following formula (A), (B), or (C).
The compound is useful as a medicament for treating neuropathic pain or pain caused by various diseases such as rheumatoid arthritis and osteoarthritis, and inflammation.
HETEROCYCLIC DERIVATIVES AS GPCR RECEPTOR AGONISTS
申请人:Fyfe Matthew
公开号:US20090281060A1
公开(公告)日:2009-11-12
Compounds of Formula (I), R
1
-A-V—B—R
2
; or pharmaceutically acceptable salts thereof, are agonists of GPR116 and are useful as regulators of satiety, e.g. for the treatment of obesity, and for the treatment of diabetes.